Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
Am J Clin Dermatol ; 18(3): 419-427, 2017 06.
Article in English | MEDLINE | ID: mdl-28035649

ABSTRACT

BACKGROUND: Although melanoma is more common in non-Hispanic Whites, ethnic minorities face a greater risk of melanoma-related mortality, which may be partially attributed to presentation at atypical sites and a lack of awareness. OBJECTIVE: Our objective was to assess the effectiveness of a melanoma educational intervention targeted towards people of color. DESIGN: Participants received one of two scripted melanoma educational interventions in the summer of 2015. They completed surveys before the intervention, immediately post-intervention, and 2 months post-intervention. SETTING: Dermatology clinic at an academic hospital. PARTICIPANTS: A consecutive sample of 100 participants who self-identified as African American, Asian, or Hispanic were recruited following their dermatology visit. In total, 70 participants completed the 2-month follow-up questionnaire. INTERVENTION: The comparison intervention group received an educational intervention using a conventional pamphlet on the 'ABCDEs' (Asymmetry, Borders, Color, Diameter, Evolution) of melanoma. The targeted intervention group received a modified pamphlet that included a skin of color section, the nomenclature "melanoma skin cancer", and an image of an individual performing a skin self-examination with the help of a friend. MAIN OUTCOMES AND MEASURES: Melanoma knowledge, perceived risk for developing melanoma, and skin self-examination practices were assessed through self-reported questionnaires. RESULTS: Among the 100 participants, 78% self-identified as African American, 11% as Asian, and 11% as Hispanic. Both groups experienced a similar increase in melanoma knowledge that was retained at 2 months. Perceived personal risk for developing melanoma increased more in the targeted intervention group immediately post-intervention (p = 0.015), but this difference no longer existed between the groups at the 2-month follow-up. The targeted intervention group also demonstrated a greater increase in skin self-examinations (p = 0.048) and knowledge of warning signs to look for when examining the skin (p = 0.002) at the 2-month follow-up. CONCLUSIONS AND RELEVANCE: The educational intervention targeted towards people of color resulted in increased skin self-examinations. Educational material that is relevant to ethnic minorities may better promote early detection and help to decrease the disparity in melanoma-related morality rates. TRIAL REGISTRATION: Clinicaltrials.gov registration number NCT02437305.


Subject(s)
Health Knowledge, Attitudes, Practice , Melanoma/diagnosis , Patient Education as Topic/methods , Skin Neoplasms/diagnosis , Adolescent , Adult , Black or African American/statistics & numerical data , Aged , Asian/statistics & numerical data , Early Detection of Cancer , Female , Follow-Up Studies , Hispanic or Latino/statistics & numerical data , Humans , Male , Melanoma/prevention & control , Middle Aged , Self-Examination , Skin Neoplasms/prevention & control , Skin Pigmentation , Surveys and Questionnaires , Young Adult
3.
J Am Acad Dermatol ; 75(4): 681-687.e11, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27544489

ABSTRACT

BACKGROUND: Previous studies found conflicting results about whether childhood atopic dermatitis (AD) persists into adulthood. OBJECTIVE: We sought to determine persistence rates and clinical factors associated with prolonged AD. METHODS: A systematic review was performed in MEDLINE, EMBASE, Scopus, GREAT, LILACS, Web of Science, Academic Search Complete, and Cochrane Library. Meta-analysis was performed using Kaplan-Meier plots and random-effects proportional hazards regression. RESULTS: In total, 45 studies including 110,651 subjects spanning 434,992 patient-years from 15 countries were included. In pooled analysis, 80% of childhood AD did not persist by 8 years and less than 5% persisted by 20 years after diagnosis (mean ± SE: 6.1 ± 0.02 years). Children with AD that persisted already for more than 10 years (8.3 ± 0.08 years) had longer persistence than those with 3 (3.2 ± 0.02 years) or 5 (6.8 ± 0.06 years) years of persistence. Children who developed AD by age 2 years had less persistent disease (P < .0001). Persistence was greater in studies using patient-/caregiver-assessed versus physician-assessed outcomes, female versus male patients (P ≤ .0006), but not in those with sensitivity to allergens (P = .90). Three studies found prolonged persistence with more severe AD. LIMITATIONS: Some studies did not capture recurrences later in life. CONCLUSIONS: Most childhood AD remitted by adulthood. However, children with already persistent disease, later onset, and/or more severe disease have increased persistence.


Subject(s)
Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/epidemiology , Adolescent , Adult , Age Factors , Age of Onset , Allergens/immunology , Child , Child, Preschool , Dermatitis, Atopic/therapy , Female , Humans , Kaplan-Meier Estimate , Male , Patch Tests , Prognosis , Proportional Hazards Models , Recurrence , Risk Assessment , Severity of Illness Index , Sex Factors , Young Adult
4.
Nanomedicine (Lond) ; 8(12): 1913-25, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23631502

ABSTRACT

AIM: The aim of this work is to evaluate combining targeting strategy and convection-enhanced delivery in brain tumor models by imaging quantum dot-immunoliposome hybrid nanoparticles. MATERIALS & METHODS: An EGF receptor-targeted, quantum dot-immunoliposome hybrid nanoparticle (QD-IL) was synthesized. In vitro uptake was measured by flow cytometry and intracellular localization was imaged by confocal microscopy. In the in vivo study, QD-ILs were delivered to intracranial xenografts via convection-enhanced delivery and fluorescence was monitored noninvasively in real-time. RESULTS: QD-ILs exhibited specific and efficient uptake in vitro and exhibited approximately 1.3- to 5.0-fold higher total fluorescence compared with nontargeted counterpart in intracranial brain tumor xenografts in vivo. CONCLUSION: QD-ILs serve as an effective imaging agent in vitro and in vivo, and the data suggest that ligand-directed liposomal nanoparticles in conjunction with convection-enhanced delivery may offer therapeutic benefits for glioblastoma treatment as a result of specific and efficient uptake by malignant cells.


Subject(s)
Brain Neoplasms/metabolism , Brain/pathology , Drug Delivery Systems , ErbB Receptors/metabolism , Glioblastoma/metabolism , Liposomes/metabolism , Quantum Dots/metabolism , Animals , Brain/metabolism , Brain Neoplasms/pathology , Cell Line, Tumor , Convection , Female , Glioblastoma/pathology , Humans , Liposomes/analysis , Mice , Mice, Inbred BALB C , Mice, Nude , Quantum Dots/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...